Venture

LOGO 9-01

Affiliations

Columbia University

Technologies

Therapeutic

Indication

Immunotherapy

Neurology

Oncology

Vesselon is commercializing a drug delivery platform that significantly increases the biodistribution of small molecules, large antibodies, or viral vectors directly to the target tissue by repurposing an FDA-approved microbubble (Imagent(R)) for drug delivery, without having to change the therapeutic agent in any way.

Vesselon Team: